We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Vitamin D Insufficiency Linked to Development of Crohn's Disease

By LabMedica International staff writers
Posted on 09 Feb 2010
Results published in a recent paper suggest that supplementing the diet with vitamin D can protect against development of Crohn's disease, a chronic incurable inflammatory bowel condition.

Vitamin D signaling through the vitamin D receptor has emerged as a key regulator of innate immunity in humans. More...
Investigators at McGill University (Montreal, Canada) extended this observation to the serious autoimmune syndrome known as Crohn's disease.

They reported in the January 22, 2010, edition of the Journal of Biological Chemistry that vitamin D acted directly to stimulate two genes that could be related to the development of Crohn's disease. The first, the beta defensin 2 gene, encodes an antimicrobial peptide that interacts with intestinal bacteria. The second, the NOD2 gene, alerts immune cells to the presence of invading microbes. When vitamin D levels were insufficient, these two genes malfunctioned, which induced the type of inflammatory response found in Crohn's disease.

"Our data suggests, for the first time, that vitamin D deficiency can contribute to Crohn's disease," said Dr. John White, professor of physiology at McGill University. "It is a defect in innate immune handling of intestinal bacteria that leads to an inflammatory response that may lead to an autoimmune condition."

"Siblings of patients with Crohn's disease that have not yet developed the disease might be well advised to make sure they are vitamin D sufficient," said Dr. White. "It is something that is easy to do, because they can simply go to a pharmacy and buy vitamin D supplements. The vast majority of people would be candidates for vitamin D treatment."

Related Links:

McGill University



Gold Member
Veterinary Hematology Analyzer
Exigo H400
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Host Response Immunoassay Test
MeMed BV
New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.